Autolus Therapeutics (AUTL) Deferred Taxes (2022 - 2025)

Autolus Therapeutics' Deferred Taxes history spans 4 years, with the latest figure at $1.2 million for Q4 2025.

  • For Q4 2025, Deferred Taxes rose 929.79% year-over-year to $1.2 million; the TTM value through Dec 2025 reached $286000.0, up 54.59%, while the annual FY2025 figure was $286000.0, 54.59% up from the prior year.
  • Deferred Taxes reached $1.2 million in Q4 2025 per AUTL's latest filing, up from -$13000.0 in the prior quarter.
  • In the past five years, Deferred Taxes ranged from a high of $1.2 million in Q4 2025 to a low of -$487000.0 in Q1 2025.
  • Average Deferred Taxes over 4 years is $87538.5, with a median of $87000.0 recorded in 2023.
  • The largest YoY upside for Deferred Taxes was 929.79% in 2025 against a maximum downside of 418.92% in 2025.
  • A 4-year view of Deferred Taxes shows it stood at -$319000.0 in 2022, then skyrocketed by 246.08% to $466000.0 in 2023, then tumbled by 130.26% to -$141000.0 in 2024, then surged by 929.79% to $1.2 million in 2025.
  • Per Business Quant, the three most recent readings for AUTL's Deferred Taxes are $1.2 million (Q4 2025), -$13000.0 (Q3 2025), and -$384000.0 (Q2 2025).